Lataa...
Azacitidine in the management of patients with myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoeitic disorders characterized by ineffective hematopoiesis and potential transformation to acute myeloid leukemia (AML). For decades, the mainstay of treatment for MDS was supportive care, including transfusion of blood prod...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627328/ https://ncbi.nlm.nih.gov/pubmed/23606938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712464882 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|